None listed
Conditions
Interventions
Drug : - propofol: 25-75mcg/kg/min continuous infusion
- dexmedetomidine: 1mcg/kg loading for 10 minutes followed by 0.2-1.0mcg/kg/hr continuous infusion
- remimazolam: 0.3-1mg/kg/hr continuous infusi
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: *ASA physical status 1-3 *age: 19-80 years *patients who were scheduled to undergo upper limb surgery under brachial plexus block with monitored anesthetic care
Exclusion criteria
Exclusion criteria: * patients who refused to participate in this study * patients with uncontrolled hypertension, hyperthyroidism, or moderate cardiac disease * patients with severe hepatic/renal disease * patients with chronic use of anti-depressant, anti-convulsant, psychotic drugs * patients who abuses drugs or alcohol * patients with severe obstructive sleep apnea * patients with severe communicatino difficulties due to cognitive impairment * patients with allergy to propofol, dexmedetomidine, or remimazolam * patients who are judged inappropriate by attending anesthesiologists to participate in this study for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time taken for MOAA/S to return to 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| Alderete score;duration of brachial plexus block;time taken for MOAA/S to 3 | — |
Countries
Korea, Republic of
Contacts
Public ContactHa-Jung Kim
Asan Medical Center
Outcome results
None listed